The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, September 28, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para.
Sofia, Bulgaria, September 27, 2021 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD notifies that on September 24, 2021 the Company bought 300 000 own shares representing 0.2226% of the share capital of the Company, at a total value of BGN 1 122 000 on the Bulgarian Stock Exchange, the average price per share was 3.740 BGN.
The total number of treasury shares after this transaction is 10 111 467, representing 7.501% of the share capital of the Company.